Literature DB >> 10053112

Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.

E R Kost1, D G Mutch, T J Herzog.   

Abstract

OBJECTIVE: Utilizing ovarian cancer cell lines, we examined the effect of IFN-gamma on each type of TNF receptor. Additionally, we sought to determine the effect of receptor modulation on TNF-alpha-mediated cytolysis.
METHODS: Ovarian cancer cell lines Caov-3, A2780, and SK-OV-3 were employed. The number of TNF receptors was determined by a TNF-alpha binding assay utilizing 125I-labeled TNF-alpha. Monoclonal antibodies specific for the 55- to 60-kDa (TR60) and the 75- to 80-kDa (TR80) TNF receptors were used to determine the relative density of each receptor type. Northern blot analyses were performed employing cDNA probes for the TR60 and TR80 mRNAs. To elucidate which receptor(s) was responsible for mediating the signal for cytolysis, 24-h MTT cytolytic assays were performed in the presence of receptor-specific monoclonal antibodies.
RESULTS: IFN-gamma treatment resulted in an increase in TNF receptors in the cell lines A2780 and Caov-3 (P < 0.001), but not SK-OV-3. Northern blot analyses suggested distinct regulatory mechanisms for the two receptors. In Caov-3 and SK-OV-3 cells a synergistic increase in TNF-alpha-mediated cytolysis was seen when cells were pretreated with IFN-gamma. In both cell lines, pretreatment with IFN-gamma markedly enhanced the ability of the TR60 receptor to mediate cell lysis. Conversely, under similar treatment conditions, the TR80 receptor did not appear capable of generating a cytolytic signal.
CONCLUSIONS: TNF receptor modulation by IFN-gamma appears to be unique to individual cell lines. The TR60 TNF receptor plays a central role in the synergistic cytolytic effects of IFN-gamma and TNF-alpha. Sequential therapy with IFN-gamma and TNF-alpha and specific TNF receptor activation may provide novel translational strategies for the use of cytokines in the treatment of ovarian cancer. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10053112     DOI: 10.1006/gyno.1998.5257

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

Review 1.  Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways.

Authors:  Omar Tliba; Yassine Amrani
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

2.  TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein.

Authors:  Deborah L Clarke; Rachel L Clifford; Sarawut Jindarat; David Proud; Linhua Pang; Maria Belvisi; Alan J Knox
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

3.  Alteration in the responsiveness to tumour necrosis factor-alpha is crucial for maximal expression of monocyte chemoattractant protein-1 in human neutrophils.

Authors:  S Yamashiro; H Kamohara; T Yoshimura
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

Review 4.  Transcriptional regulation of cytokine function in airway smooth muscle cells.

Authors:  Deborah Clarke; Gautam Damera; Maria B Sukkar; Omar Tliba
Journal:  Pulm Pharmacol Ther       Date:  2009-04-22       Impact factor: 3.410

5.  CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.

Authors:  Jillian A Bristol; Thomas E Morrison; Shannon C Kenney
Journal:  Mol Immunol       Date:  2009-06-11       Impact factor: 4.407

6.  Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth.

Authors:  Jing Shen; Zhi Jie Li; Long Fei Li; Lan Lu; Zhan Gang Xiao; William Ka Kei Wu; Lin Zhang; Ming Xing Li; Wei Hu; Kam Ming Chan; Chi Hin Cho
Journal:  J Transl Med       Date:  2016-06-24       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.